e-learning
resources
Berlin 2001
Sunday 23.09.2001
Treatment of LRTI
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapy of pulmonary aspergillosis with newly developed azole-derivatives
H. Grysczyk, A. de Roux, H. Mauch, A. Grassot, H. Lode (Berlin, Germany)
Source:
Annual Congress 2001 - Treatment of LRTI
Session:
Treatment of LRTI
Session type:
Thematic Poster Session
Number:
928
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Grysczyk, A. de Roux, H. Mauch, A. Grassot, H. Lode (Berlin, Germany). Therapy of pulmonary aspergillosis with newly developed azole-derivatives. Eur Respir J 2001; 16: Suppl. 31, 928
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015
Surgery treatment of pulmonary aspergillosis
Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Year: 2007
Pulmonary aspergillosis – diagnostic and therapeutic challenges
Source: Eur Respir J 2005; 26: Suppl. 49, 170s
Year: 2005
PET‘s importance in chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation
Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018
Year: 2019
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis
Source: Eur Respir J 2012; 40: 271-273
Year: 2012
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients
Source: Eur Respir J 2001 Jan 01;19(4):743-755
Year: 2002
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
Source: Eur Respir Rev 2010 19: 349-351
Year: 2010
Surgical and clinical assessment of pulmonary aspergillosis secondary to sequelar TB cavities
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011
Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017
Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept